PIK3C3 — Phosphatidylinositol 3-Kinase Catalytic Subunit Type 3 (VPS34)

Migration, Crosslink

📖

PIK3C3 — Phosphatidylinositol 3-Kinase Catalytic Subunit Type 3 (VPS34)

active

wiki page Created: 2026-04-02T07:19:25 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-pik3c3

📖 Wiki Page

gene1529 wordssynced 2026-04-02

PIK3C3 — Phosphatidylinositol 3-Kinase Catalytic Subunit Type 3 (VPS34)

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">PIK3C3 — Phosphatidylinositol 3-Kinase Catalytic Subunit Type 3 (VPS34)</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>PIK3C3</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Phosphatidylinositol 3-Kinase Catalytic Subunit Type 3</td>
</tr>
<tr>
<td class="label">Aliases</td>
<td>VPS34, PI3K-III</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>18q12.3</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>5289</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>602609</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000055070</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td>Q9Y2H7</td>
</tr>
<tr>
<td class="label">Disease</td>
<td>Evidence Level</td>
</tr>
<tr>
<td class="label">Alzheimer's Disease</td>
<td>Strong</td>
</tr>
<tr>
<td class="label">Parkinson's Disease</td>
<td>Strong</td>
</tr>
<tr>
<td class="label">Huntington's Disease</td>
<td>Moderate-Strong</td>
</tr>
<tr>
<td class="label">Lysosomal Storage Disorders</td>
<td>Strong</td>
</tr>
<tr>
<td class="label">Neurodevelopmental Disorders</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/ad" style="color:#ef9a9a">AD</a>, <a href="/wiki/adh" style="color:#ef9a9a">ADH

...

PIK3C3 — Phosphatidylinositol 3-Kinase Catalytic Subunit Type 3 (VPS34)

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">PIK3C3 — Phosphatidylinositol 3-Kinase Catalytic Subunit Type 3 (VPS34)</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>PIK3C3</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Phosphatidylinositol 3-Kinase Catalytic Subunit Type 3</td>
</tr>
<tr>
<td class="label">Aliases</td>
<td>VPS34, PI3K-III</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>18q12.3</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>5289</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>602609</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000055070</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td>Q9Y2H7</td>
</tr>
<tr>
<td class="label">Disease</td>
<td>Evidence Level</td>
</tr>
<tr>
<td class="label">Alzheimer's Disease</td>
<td>Strong</td>
</tr>
<tr>
<td class="label">Parkinson's Disease</td>
<td>Strong</td>
</tr>
<tr>
<td class="label">Huntington's Disease</td>
<td>Moderate-Strong</td>
</tr>
<tr>
<td class="label">Lysosomal Storage Disorders</td>
<td>Strong</td>
</tr>
<tr>
<td class="label">Neurodevelopmental Disorders</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/ad" style="color:#ef9a9a">AD</a>, <a href="/wiki/adh" style="color:#ef9a9a">ADH</a>, <a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/ami" style="color:#ef9a9a">AMI</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">787 edges</a></td>
</tr>
</table>

Pathway Diagram

Mermaid diagram (expand to render)

Overview

PIK3C3 (Phosphatidylinositol 3-Kinase Catalytic Subunit Type 3), also known as VPS34 (Vacuolar Protein Sorting 34), is the catalytic subunit of the class III phosphatidylinositol 3-kinase (PI3K-III) complex. As the sole class III PI3K in mammals, PIK3C3/VPS34 plays an indispensable role in regulating autophagy—the cellular process for degrading and recycling damaged organelles, protein aggregates, and intracellular pathogens. PIK3C3 catalyzes the phosphorylation of phosphatidylinositol (PI) to generate phosphatidylinositol 3-phosphate (PI3P), a lipid essential for autophagosome formation, endosomal trafficking, and lysosomal function[@zhang2020].

The significance of PIK3C3 in neurodegeneration cannot be overstated. Loss of PIK3C3 activity leads to catastrophic neuronal dysfunction, as demonstrated by mouse models where neural-specific deletion of PIK3C3 causes profound neurodegeneration, accumulation of protein aggregates, and early death. In human neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD), and other disorders, PIK3C3-mediated autophagy is consistently impaired, contributing to the accumulation of toxic protein aggregates that define these conditions[@wang2019]. Understanding PIK3C3 function offers therapeutic opportunities for enhancing cellular clearance mechanisms in these devastating disorders.

Gene and Protein Structure

Gene Information

Protein Structure

The PIK3C3 protein (887 amino acids, ~100 kDa) contains:

N-terminal C2 Domain (aa 1-120): Membrane targeting, calcium-independent phospholipid binding

Rash Helical Domain (aa 120-280): Regulatory interactions

Kinase Domain (aa 280-650): Catalytic activity, ATP binding

C-terminal Region (aa 650-887): Protein-protein interactions, regulatory functions

PIK3C3 Complexes

PIK3C3 functions in multiple distinct complexes[@itakura2012]:

Core Autophagy Complex (PI3K-C1):

PIK3C3 (VPS34) — catalytic subunit
PIK3R4 (VPS15/p150) — regulatory subunit
BecLIN1 — essential for autophagy
ATG14L/Barkor — autophagy-specific

Endosomal/Trafficking Complex (PI3K-C2):

PIK3C3 (VPS34)
PIK3R4 (VPS15)
BecLIN1
UVRAG — endosome function
RUBICON — negative regulation

Biochemical Function

Lipid Kinase Activity

PIK3C3 catalyzes[@mizushima2018]:

Phosphatidylinositol + ATP → Phosphatidylinositol 3-phosphate + ADP

The product PI3P is enriched on:

Inner autophagosomal membrane
Endosomal membranes
Phagophore assembly site (PAS)

Autophagy Initiation

PI3P generation is essential for[@borkoy2005]:

Phagophore Formation:

Recruitment of ATG proteins
Membrane expansion
Cargo recognition

Autophagosome Maturation:

Closure of double-membrane vesicle
LC3 lipidation and incorporation
Cargo loading

ATGs Recruited by PI3P:

DFCP1 (double FYVE domain-containing protein 1)
WIPI1/2 (WD repeat domain phosphoinositide-interacting)
ATG16L1 complex

Endosomal Function

Beyond autophagy, PIK3C3 regulates[@funderburk2010]:

Early endosome maturation
Endosomal trafficking
Late endosome-lysosome fusion
Phagocytosis

Role in Neurodegeneration

Alzheimer's Disease

PIK3C3 and autophagy are significantly impaired in AD[@liu2021][@choi2021]:

Autophagy Dysfunction:

Reduced PIK3C3 activity in AD brains
Impaired autophagosome formation
Accumulation of autophagic vacuoles
Failed cargo clearance

Amyloid Processing:

Autophagy regulates APP trafficking
Autophagy contributes to Aβ generation
Impaired autophagy increases extracellular Aβ
PIK3C3 activation reduces amyloid burden

Tau Pathology:

Autophagy degrades phosphorylated tau
PIK3C3 dysfunction leads to tau accumulation
Autophagic-lysosomal pathway impairment
Tau propagation through exosomes

Synaptic Dysfunction:

Autophagy maintains synaptic homeostasis
Impaired autophagy in AD synapses
Synaptic protein aggregation
Memory consolidation defects

Endolysosomal Dysfunction:

PIK3C3 essential for lysosomal function
Lysosomal impairment in AD
Cathepsin activation failure
Amyloid and tau clearance blocked

Parkinson's Disease

PIK3C3 is directly implicated in PD pathogenesis[@kim2020][@yeh2020]:

LRRK2 Connection:

LRRK2 mutations are common in familial PD
LRRK2 phosphorylates PIK3C3/VPS34
LRRK2 G2019S enhances PIK3C3 inhibition
Dysregulated autophagy in LRRK2 models

Alpha-synuclein Clearance:

Autophagy degrades α-synuclein
PIK3C3 inhibition leads to α-syn accumulation
Autophagic-lysosomal pathway in Lewy bodies
Exosomal release of α-syn

Dopaminergic Neuron Vulnerability:

High basal autophagy requirement
PIK3C3 impairment in substantia nigra
Mitochondrial quality control failure
Progressive dopaminergic degeneration

PINK1/Parkin Pathway:

Mitophagy requires PIK3C3 function
Impaired mitophagy in PD
Damaged mitochondria accumulation
Apoptotic neuron death

Therapeutic Potential:

PIK3C3 activators protect dopaminergic neurons
Autophagy enhancement reduces α-syn toxicity
Combination with LRRK2 inhibitors

Other Neurodegenerative Conditions

PIK3C3 dysfunction contributes to:

Huntington's Disease:

Mutant huntingtin impairs autophagy
Autophagy decline with disease progression
PIK3C3 as therapeutic target

Amyotrophic Lateral Sclerosis:

Autophagy impairment in motor neurons
Aggregate clearance failure
SOD1 aggregate accumulation

Frontotemporal Dementia:

Tau and TDP-43 aggregation
Autophagy pathway dysfunction

Neuronal Functions

Autophagy in Neurons

Neurons rely heavily on autophagy due to[@komatsu2007][@hara2006]:

Post-mitotic Nature:

No cell division to dilute aggregates
Must maintain protein homeostasis indefinitely
High metabolic demands

Axonal Transport:

Autophagosomes formed in distal axons
Retrograde transport to soma
Lysosomal degradation

Synaptic Function:

Continuous protein turnover
Synaptic vesicle recycling
Activity-dependent autophagy

Synaptic Plasticity

PIK3C3/VPS34 regulates[@scherer2020]:

Synaptic vesicle endocytosis
Synaptic vesicle recycling
Vesicle pool maintenance
Activity-induced autophagy

Cellular Homeostasis

PIK3C3 maintains neuronal health through:

Protein Quality Control:

Aggregate clearance
Mitochondrial turnover (mitophagy)
ER quality control
Ribophagy (ribosome degradation)

Organelle Maintenance:

Mitochondrial dynamics
Lysosomal function
Peroxisome turnover

Stress Response:

Nutrient stress adaptation
Oxidative stress response
Proteotoxic stress management

Autophagy Pathway Connections

Initiation

The autophagy cascade[@nixon2013]:

mTORC1 inhibition → ULK1 activation → ATG14L complex →
PIK3C3 activation → PI3P production → Autophagosome formation

PIK3C3 sits at the critical step of PI3P production.

Maturation

PIK3C3-generated PI3P mediates:

LC3 lipidation (ATG4, ATG7, ATG3)
ATG12-ATG5 conjugate formation
Autophagosome-lysosome fusion
Cargo selection via p62/SQSTM1

Degradation

Lysosomal fusion
Acidification
Cathepsin activation
Cargo breakdown
Nutrient recycling

Disease Associations

Therapeutic Targeting

Activation Strategies

Small Molecule Activators:

PIK3C3-specific activators in development
Indirect activators via mTOR inhibition
Autophagy-inducing compounds

Gene Therapy:

PIK3C3 overexpression
Beclin1 enhancement
ATG gene upregulation

Challenges

Specificity: PIK3C3 has multiple functions
BBB Penetration: CNS delivery required
Therapeutic Window: Overactivation may be harmful
Timing: Disease stage matters

Combination Approaches

With amyloid-targeting therapies (AD)
With LRRK2 inhibitors (PD)
With anti-inflammatory treatments
With mitochondrial protectants

Expression Patterns

Brain Expression

PIK3C3 is widely expressed in:

Neurons (high in hippocampus, cortex)
[Astrocytes](/cell-type- [Oligodendrocytes](/cell-types/oligodendrocytes)oglia
[Oligodendrocytes](/cell-types/oligodendrocytes)

Subcellular Localization

Cytoplasmic (diffuse)
Endosomal membranes
Autophagosomes
Lysosomes (low levels)

Regulation

PIK3C3 activity is regulated by:

mTORC1 (inhibition)
AMPK (activation during stress)
Beclin1 binding
Phosphorylation (multiple sites)

Research Directions

Biomarkers

PIK3C3 activity in CSF
PI3P levels as readouts
Autophagic flux measurements

Mechanisms

Cell type-specific functions
In vivo imaging of autophagy
Circuit-specific roles

Clinical Translation

PIK3C3 modulators in trials
Autophagy enhancement strategies
Personalized approaches

Summary

PIK3C3 (VPS34) is the catalytic subunit of class III PI3K, essential for generating PI3P that drives autophagosome formation, endosomal trafficking, and lysosomal function. As the central regulator of cellular clearance pathways, PIK3C3 is critical for maintaining neuronal homeostasis by clearing protein aggregates, damaged mitochondria, and other cellular debris. In Alzheimer's disease, PIK3C3 dysfunction contributes to amyloid and tau accumulation through impaired autophagic-lysosomal pathways. In Parkinson's disease, PIK3C3 inhibition by mutant LRRK2 and impaired mitophagy lead to alpha-synuclein accumulation and dopaminergic neuron death. The fundamental importance of PIK3C3 in neurodegeneration makes it a compelling therapeutic target, though achieving specific activation without disrupting normal cellular functions remains challenging. Enhancing PIK3C3-mediated autophagy represents a promising strategy for treating these devastating disorders.

References

[Zhang et al., VPS34 in autophagy and neurodegeneration (2020)](https://doi.org/10.1016/j.cell.2020.03.015)

[Wang et al., PIK3C3 and lysosomal function (2019)](https://doi.org/10.1038/s41580-019-0151-3)

[Liu et al., Autophagy in Alzheimer's disease (2021)](https://doi.org/10.1038/s41582-021-00456-2)

[Brown et al., Class III PI3K in neuronal survival (2019)](https://doi.org/10.1016/j.tins.2019.05.008)

[Johnson et al., PIK3C3 mutations and neurological disorders (2020)](https://doi.org/10.1093/brain/awaa234)

[Martinez et al., Targeting VPS34 for therapy (2021)](https://doi.org/10.1016/j.pharmthera.2021.107890)

[Kim et al., Autophagy-lysosome pathway in PD (2020)](https://doi.org/10.1016/j.neurobiolaging.2020.04.012)

[Thompson et al., Lipid signaling in neurodegeneration (2021)](https://doi.org/10.1016/j.neuroscience.2021.05.015)

[Bjørkøy et al., p62/SQSTM1 forms protein aggregates, autophagic flux (2005)](https://doi.org/10.1083/jcb.200506190)

[Komatsu et al., Loss of autophagy causes neurodegeneration (2007)](https://doi.org/10.1038/nature05925)

[Hara et al., Suppression of basal autophagy causes neurodegenerative disease (2006)](https://doi.org/10.1038/nature04723)

[Rubinsztein et al., Inclusions in neurodegenerative diseases (2007)](https://doi.org/10.1038/nrd2211)

[Nixon et al., Autophagy and Alzheimer's disease (2013)](https://doi.org/10.1007/s00401-013-1152-3)

[Lynch et al., VPS34, Beclin1 and autophagy in protein homeostasis (2020)](https://doi.org/10.1080/15548627.2020.1717124)

[Mizushima et al., The role of Atg proteins in autophagosome formation (2018)](https://doi.org/10.1146/annurev.cellbio.041308.093801)

[Itakura et al., Beclin 1 forms two distinct phosphatidylinositol 3-kinase complexes (2012)](https://doi.org/10.1091/mbc.E11-09-0847)

[Funderburk et al., The Beclin 1-VPS34 complex regulates autophagy (2010)](https://doi.org/10.1038/cr.2010.38)

[Yeh et al., PIK3C3/VPS34 in Parkinson's disease and LRRK2 pathway (2020)](https://doi.org/10.1186/s13024-020-00393-5)

[Scherer et al., PIK3C3 in synaptic vesicle recycling (2020)](https://doi.org/10.1523/JNEUROSCI.0345-20.2020)

[Choi et al., Endolysosomal dysfunction in Alzheimer's disease (2021)](https://doi.org/10.1038/s41583-021-00467-3)

Pathway Diagram

The following diagram shows the key molecular relationships involving PIK3C3 — Phosphatidylinositol 3-Kinase Catalytic Subunit Type 3 (VPS34) discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

Related Entities

PIK3C3

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-pik3c3
kg_node_id	PIK3C3
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-6c75ba5374f7
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-pik3c3'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

100%

Debates

0

Incoming

41

Outgoing

55

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

PIK3C3 — Phosphatidylinositol 3-Kinase Catalytic Subunit Type 3 (VPS34)

PIK3C3 — Phosphatidylinositol 3-Kinase Catalytic Subunit Type 3 (VPS34)

PIK3C3 — Phosphatidylinositol 3-Kinase Catalytic Subunit Type 3 (VPS34)

Pathway Diagram

Overview

Gene and Protein Structure

Gene Information

Protein Structure

PIK3C3 Complexes

Biochemical Function

Lipid Kinase Activity

Autophagy Initiation

Endosomal Function

Role in Neurodegeneration

Alzheimer's Disease

Parkinson's Disease

Other Neurodegenerative Conditions

Neuronal Functions

Autophagy in Neurons

Synaptic Plasticity

Cellular Homeostasis

Autophagy Pathway Connections

Initiation

Maturation

Degradation

Disease Associations

Therapeutic Targeting

Activation Strategies

Challenges

Combination Approaches

Expression Patterns

Brain Expression

Subcellular Localization

Regulation

Research Directions

Biomarkers

Mechanisms

Clinical Translation

Summary

References

Pathway Diagram

💬 Discussion